Xin Luo

Xin Luo, Wei Chen, Yusong Tan et al.

It is desirable to transfer the knowledge stored in a well-trained source model onto non-annotated target domain in the absence of source data. However, state-of-the-art methods for source free domain adaptation (SFDA) are subject to strict limits: 1) access to internal specifications of source models is a must; and 2) pseudo labels should be clean during self-training, making critical tasks relying on semantic segmentation unreliable. Aiming at these pitfalls, this study develops a domain adaptive solution to semantic segmentation with pseudo label rectification (namely \textit{PR-SFDA}), which operates in two phases: 1) \textit{Confidence-regularized unsupervised learning}: Maximum squares loss applies to regularize the target model to ensure the confidence in prediction; and 2) \textit{Noise-aware pseudo label learning}: Negative learning enables tolerance to noisy pseudo labels in training, meanwhile positive learning achieves fast convergence. Extensive experiments have been performed on domain adaptive semantic segmentation benchmark, \textit{GTA5 $\to$ Cityscapes}. Overall, \textit{PR-SFDA} achieves a performance of 49.0 mIoU, which is very close to that of the state-of-the-art counterparts. Note that the latter demand accesses to the source model's internal specifications, whereas the \textit{PR-SFDA} solution needs none as a sharp contrast.

Shidan Wang, Tao Wang, Lin Yang et al.

The spatial distributions of different types of cells could reveal a cancer cell growth pattern, its relationships with the tumor microenvironment and the immune response of the body, all of which represent key hallmarks of cancer. However, manually recognizing and localizing all the cells in pathology slides are almost impossible. In this study, we developed an automated cell type classification pipeline, ConvPath, which includes nuclei segmentation, convolutional neural network-based tumor, stromal and lymphocytes classification, and extraction of tumor microenvironment related features for lung cancer pathology images. The overall classification accuracy is 92.9% and 90.1% in training and independent testing datasets, respectively. By identifying cells and classifying cell types, this pipeline can convert a pathology image into a spatial map of tumor, stromal and lymphocyte cells. From this spatial map, we can extracted features that characterize the tumor micro-environment. Based on these features, we developed an image feature-based prognostic model and validated the model in two independent cohorts. The predicted risk group serves as an independent prognostic factor, after adjusting for clinical variables that include age, gender, smoking status, and stage.